tnf
gene
encod
tumour
necrosi
factor
tnf
resid
central
part
class
iii
region
major
histocompat
complex
mhc
surround
larg
number
immunolog
gene
special
locu
gene
deduc
gene
may
associ
mani
diseas
hypothesi
confirm
mani
research
result
key
mediat
inflammatori
respons
critic
host
defens
wide
varieti
pathogen
microb
howev
overexpress
cytokin
may
lead
bad
diseas
recoveri
dual
role
tnf
act
agent
innat
immun
inflammatori
patholog
pose
consider
challeng
gene
regul
regul
mainli
locat
promot
region
gene
capac
cytokin
product
individu
major
genet
compon
strike
differ
exist
among
individu
term
abil
produc
cytokin
sever
biallel
polymorph
describ
within
gene
includ
seven
promot
region
posit
base
pair
transcript
start
site
moreov
number
studi
shown
promot
polymorph
signific
effect
transcript
activ
sever
acut
respiratori
syndrom
sar
newli
describ
human
infecti
diseas
caus
novel
coronavirussarscov
sarscov
infect
import
high
infect
unpredict
clinic
cours
character
high
mortal
rate
till
mani
research
report
suscept
infect
sarscov
may
associ
hla
mxa
gene
polymorph
yet
result
variabl
differ
popul
exampl
ng
report
sarscov
infect
associ
hlab
hongkong
popul
howev
lin
result
show
hlab
hlab
close
relat
sarscov
infect
chan
report
attribut
sarscov
infect
zhi
result
fail
support
differ
may
attribut
studi
popul
use
report
also
complex
mechan
infect
sarscov
consid
anoth
factor
differ
order
explor
host
factor
influenc
occurr
sarscov
infect
studi
polymorph
gene
promot
region
ascrib
polymorph
within
regulatori
region
signal
sequenc
cytokin
gene
discharg
hospit
interstiti
lung
fibrosi
observ
sar
patient
clinic
data
show
preval
rate
chang
cure
sar
patient
nine
month
discharg
one
earliest
cytokin
implic
pathogenesi
lung
fibrosi
diseas
togeth
found
overexpress
regener
type
ii
pneumocyt
human
lung
thu
enhanc
fibroblast
prolifer
polymorph
discov
significantli
associ
increas
risk
develop
pulmonari
fibrosi
given
genet
variat
may
potenti
alter
inflamm
fibrosi
lung
aim
casecas
control
studi
examin
polymorph
interstiti
lung
fibrosi
sar
patient
spite
interstiti
lung
fibrosi
cure
sar
patient
anoth
sequela
femor
head
necrosi
also
observ
popul
preval
rate
tianjin
beij
patient
respect
caus
diseas
still
unknown
argument
exampl
author
consid
sarscov
caus
femor
head
necrosi
yet
author
disagre
view
previou
studi
show
femor
head
necrosi
may
caus
hormon
usag
yet
data
fail
agre
point
need
studi
explor
caus
sequela
polymorph
consid
first
report
paper
aim
studi
whether
polymorph
promot
region
associ
sarscov
infect
develop
progress
interstiti
lung
fibrosi
femor
head
necrosi
cure
sar
patient
studi
review
approv
ethic
committe
medic
colleg
cpafp
studi
popul
compris
sar
patient
pingjin
hospit
tianjin
china
health
care
worker
hospit
come
contact
sar
patient
develop
sar
individu
contact
histori
sar
patient
among
sar
patient
could
classifi
sever
light
sar
accord
clinic
condit
histori
hospit
period
popul
also
histori
hormon
therapi
review
clinic
treatment
antisarscov
antibodi
serum
sampl
test
sar
elisa
kit
huada
diagnost
ltd
beij
china
consid
progress
interstiti
lung
fibrosi
femor
head
necrosi
may
affect
hormon
therapi
hormon
use
dosag
method
last
period
consid
studi
analyz
associ
gene
polymorph
diseas
three
kind
hormon
use
sar
patient
includ
methylprednisolon
deltadehydrocortison
dexamethason
order
simplifi
analyz
deltadehydrocortison
dexamethason
dosag
calcul
methylprednisolon
use
follow
equat
mg
methylprednisolon
mg
deltadehydrocortison
mg
dexamethason
lash
therapi
mean
mg
methylprednisolon
use
singl
day
cure
sar
patient
interstiti
lung
fibrosi
diagnos
respiratori
expert
accord
ct
result
follow
standard
propos
therapi
diagnosi
sar
patient
issu
chines
ministri
health
interstiti
lung
fibrosi
sar
patient
manifest
irregular
patch
strip
shadow
high
densiti
strip
shadow
honeycomb
interstiti
lung
fibrosi
chang
could
combin
bronchiectasi
femor
head
necrosi
diagnos
use
magnet
reson
imag
mri
mri
scan
normal
femor
head
would
show
uniformli
high
signal
intens
throughout
femor
head
agre
one
follow
imag
could
diagnos
femor
head
necrosi
sar
patient
abnorm
signal
clear
margin
cartilag
femor
head
doubl
thread
imag
fractur
joint
dent
cartilag
low
signal
stir
high
signal
marrow
caviti
edema
blur
edg
leucocyt
isol
within
h
blood
collect
use
percol
reagent
genom
dna
extract
use
cell
dna
extract
kit
tiangen
biotec
co
beij
china
patch
number
accord
manufactur
instruct
primer
design
accord
gewaltig
standard
polymeras
chain
reaction
pcr
contain
forward
primer
revers
primer
buffer
mm
mm
triscl
ph
mm
mm
dna
polymeras
tiangen
biotec
co
beij
china
dna
templat
amplif
carri
thermal
cycler
techn
duxford
cambridg
uk
cycl
paramet
min
initi
denatur
round
final
extens
min
reaction
carri
molecular
bioproduct
cap
tube
gave
optim
heat
transfer
thermal
cycler
gene
bp
fragment
paper
sequenc
doubl
direct
forward
primer
revers
primer
invitrogen
compani
invitrogen
co
shanghai
china
use
abi
thermal
cycler
carri
job
homozygot
genotyp
snp
site
manifest
singl
peak
yet
heterozygot
ambigu
nucleotid
posit
doubl
color
peak
big
dye
chemistri
pictur
accord
read
sequenc
graph
genotyp
determin
differ
valu
two
group
evalu
chi
analysi
frequenc
student
test
quantit
index
binari
logist
regress
done
use
spss
softwar
spss
inc
chicago
illinoi
usa
total
sar
patient
health
care
worker
individu
includ
studi
popul
chines
han
ethnic
mean
age
year
sar
health
care
worker
individu
control
sar
vs
hcw
p
sar
vs
individu
control
p
proport
male
sar
health
care
worker
individu
control
sar
vs
hcw
p
sar
vs
individu
control
p
sera
posit
rate
antisarscov
antibodi
sar
significantli
higher
health
care
worker
individu
control
sar
vs
hcw
p
sar
vs
individu
control
p
tabl
genotyp
frequenc
variabl
sar
health
care
worker
individu
control
differ
genotyp
distribut
among
three
popul
howev
ct
genotyp
less
frequent
sar
group
compar
individu
control
locu
p
compar
tt
genotyp
ct
genotyp
locu
found
associ
protect
effect
sar
ci
tabl
accord
clinic
histori
symptom
sar
patient
classifi
light
sever
complic
clinic
condit
sar
outbreak
patient
histori
incomplet
could
classifi
follow
sever
standard
sever
sar
refer
one
follow
dyspnea
time
per
min
respiratori
frequenc
still
condit
oxygen
index
less
mmhg
shock
multipl
organ
dysfunct
syndrom
among
patient
fiftyfour
classifi
light
sever
associ
polymorph
sar
sever
tabl
glucocorticoid
use
dosag
method
last
period
associ
interstiti
lung
fibrosi
femor
head
necrosi
binari
logist
analysi
sar
patient
tabl
differ
hormon
use
dosag
interstiti
lung
fibrosi
noninterstiti
lung
fibrosi
group
p
trend
also
observ
femor
head
necrosi
nonfemor
head
necrosi
group
p
tabl
allel
frequenc
polymorph
list
tabl
signific
differ
interstiti
lung
fibrosi
noninterstiti
lung
fibrosi
sar
patient
promot
region
gene
allel
frequenc
gene
compar
sar
patient
femor
head
necrosi
nonfemor
head
necrosi
tabl
ct
cc
genotyp
frequent
sar
patient
femor
head
necrosi
respect
nonfemor
head
necrosi
respect
compar
tt
genotyp
ct
cc
found
associ
risk
effect
femor
head
necrosi
or
ci
respect
adjust
ct
ci
combin
ct
cc
genotyp
ci
also
ac
genotyp
account
femor
head
necrosi
group
nonfemor
head
necrosi
compar
cc
genotyp
ac
genotyp
manifest
anoth
risk
effect
associ
femor
head
necrosi
ci
adjust
ci
cure
sar
patient
four
year
sar
occurr
mani
problem
still
remain
unknown
us
till
mani
research
report
suscept
infect
sarscov
may
associ
hla
mxa
gene
polymorph
yet
result
variabl
differ
popul
differ
may
attribut
studi
popul
use
report
also
complex
mechan
infect
sarscov
consid
anoth
factor
differ
order
explor
host
factor
influenc
occurr
sarscov
infect
studi
polymorph
gene
promot
region
ascrib
polymorph
within
regulatori
region
signal
sequenc
cytokin
gene
allel
distribut
almost
among
sar
health
care
worker
individu
control
higher
allel
frequenc
sar
popul
compar
control
locu
p
though
previou
studi
show
ag
genotyp
associ
clearanc
hepat
b
viru
infect
helicobact
pylori
caga
subtyp
infect
result
fail
show
role
locu
sarscov
infect
conclus
agre
chong
wp
et
al
found
weak
protect
effect
ct
genotyp
locu
gene
sarscov
infect
locu
new
discov
snp
site
promot
region
role
infecti
diseas
might
need
studi
time
obviou
associ
polymorph
promot
region
sever
sar
observ
howev
lu
report
polymorph
associ
outcom
hepat
b
viru
infect
thu
role
gene
infecti
diseas
studi
key
mediat
inflammatori
respons
critic
host
defens
wide
varieti
pathogen
microb
higher
concentr
cytokin
may
caus
sever
patholog
capac
cytokin
product
individu
major
genet
compon
strike
differ
exist
among
individu
term
abil
produc
cytokin
number
studi
shown
promot
polymorph
signific
effect
transcript
activ
process
sarscov
infect
cytokin
storm
patient
includ
elev
level
proinflammatori
cytokin
may
caus
immunomedi
damag
lung
organ
result
acut
lung
injuri
subsequ
multiorgan
dysfunct
genet
variat
may
potenti
alter
inflamm
fibrosi
lung
discharg
hospit
interstiti
lung
fibrosi
observ
cure
sar
patient
preval
rate
one
earliest
cytokin
implic
pathogenesi
lung
fibrosi
diseas
togeth
found
overexpress
regener
type
ii
pneumocyt
human
lung
thu
enhanc
fibroblast
prolifer
genet
polymorph
found
significantli
associ
increas
risk
develop
pulmonari
fibrosi
progress
idiopath
pulmonari
fibrosi
activ
epitheli
cell
thought
releas
potent
fibrogen
molecul
cytokin
turn
foster
transform
fibroblast
myofibroblast
promot
product
extracellular
matrix
molecul
viciou
cycl
injuri
abnorm
epitheli
heal
set
stage
progress
fibrosi
architectur
distort
lung
parenchyma
howev
data
fail
show
allel
relat
interstiti
lung
fibrosi
compar
noninterstiti
lung
fibrosi
sar
patient
time
homozygot
genotyp
tt
gg
respect
sar
patient
relationship
genotyp
interstiti
lung
fibrosi
could
calcul
result
implic
mayb
differ
mechan
interstiti
lung
fibrosi
sar
compar
idiopath
pulmonari
fibrosi
femor
head
necrosi
anoth
sequela
discharg
sar
patient
prevail
rate
tianjin
howev
caus
sequela
still
unknown
argument
exampl
author
consid
sarscov
caus
femor
head
necrosi
yet
author
disagre
view
previou
studi
show
femor
head
necrosi
may
caus
hormon
usag
data
far
agre
conclus
obviou
associ
hormon
use
includ
hormon
dosag
method
last
period
femor
head
necrosi
binari
logist
analysi
sar
patient
found
ct
cc
genotyp
frequent
sar
patient
femor
head
necrosi
respect
nonfemor
head
necrosi
respect
ct
cc
relat
risk
effect
femor
head
necrosi
or
ci
respect
compar
tt
genotyp
hormon
use
adjust
ct
ci
combin
ct
cc
genotyp
ci
also
ac
genotyp
account
femor
head
necrosi
group
nonfemor
head
necrosi
compar
cc
genotyp
ac
genotyp
manifest
anoth
risk
effect
associ
femor
head
necrosi
ci
adjust
ci
cure
sar
patient
activ
activ
osteoclast
acceler
absorpt
bone
cartilag
induc
occurr
oxygen
free
radic
lipid
peroxid
induc
ischem
necrosi
femor
head
ploymoph
gene
may
directli
indirectli
attribut
occurr
femor
head
necrosi
sar
patient
conclus
may
associ
polymorph
promot
region
sarscov
infect
also
gene
polymorph
may
affect
occurr
interstiti
lung
fibrosi
cure
sar
patient
howev
polymorph
may
relat
femor
head
necrosi
author
declar
compet
interest
sxw
conceiv
studi
particip
design
coordin
mtw
cofirst
author
carri
molecular
genet
studi
draft
manuscript
yh
kjz
lh
carri
molecular
genet
studi
zy
bs
zlz
particip
field
investig
sampl
collect
studi
ylh
wlh
particip
design
studi
perform
statist
analysi
author
contribut
write
final
manuscript
author
read
approv
final
manuscript
prepubl
histori
paper
access
